Interleukin Genetics Announces Conference Call to Discuss Third Quarter 2009 Results

WALTHAM, Mass., Nov. 5  /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today that it will host a conference call and webcast on Thursday, November 12, 2009, at 4:30 p.m. EST to review the Company's business developments and third quarter financial results.

To access the live call, dial 888-287-5529 (domestic) or 719-325-2486 (international). The live webcast and replay access of the teleconference will be available on the Investors section of the Company's website at http://www.ilgenetics.com/.

About Interleukin Genetics

Interleukin Genetics, Inc. (NYSE Amex: ILI) develops and markets genetic tests under the Inherent Health(TM) brand that empower consumers to prevent chronic diseases and assists pharmaceutical companies in the development and marketing of targeted therapeutics. The Company leverages its research, intellectual property and biomarker development experience to facilitate the emerging personalized health market. Interleukin Genetics is headquartered in Waltham, MA.  For more information please visit http://www.ilgenetics.com/. 

DATASOURCE: Interleukin Genetics, Inc.



CONTACT:  Media, Erin Walsh of Interleukin Genetics, [phone],





Web Site:  http://www.ilgenetics.com/ 

Copyright